Related references
Note: Only part of the references are listed.Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2015)
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass
David J. Bonda et al.
NEUROSCIENCE BULLETIN (2014)
Deletion of the eIF2α Kinase GCN2 Fails to Rescue the Memory Decline Associated with Alzheimer's Disease
Latha Devi et al.
PLOS ONE (2013)
Elevation of glutathione as a therapeutic strategy in Alzheimer disease
Chava B. Pocernich et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics
P. Hemachandra Reddy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
Patrizia Mecocci et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimers disease neurons: implications for mitochondrial dysfunction and neuronal damage
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2012)
Mitochondria-targeted catalase reduces abnormal APP processing, amyloid production and BACE1 in a mouse model of Alzheimers disease: implications for neuroprotection and lifespan extension
Peizhong Mao et al.
HUMAN MOLECULAR GENETICS (2012)
Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimers disease
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2012)
Distinct Dendritic Spine and Nuclear Phases of Calcineurin Activation after Exposure to Amyloid-β Revealed by a Novel Fluorescence Resonance Energy Transfer Assay
Hai-Yan Wu et al.
JOURNAL OF NEUROSCIENCE (2012)
Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease
Eugenia Trushina et al.
PLOS ONE (2012)
Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease
Marcus J. Calkins et al.
PHARMACEUTICALS (2012)
Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage
Marcus J. Calkins et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2011)
Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease
Marcus J. Calkins et al.
HUMAN MOLECULAR GENETICS (2011)
Amyloid-beta and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline
P. Hemachandra Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Mitochondria-Targeted Antioxidants Protect Against Amyloid-beta Toxicity in Alzheimer's Disease Neurons
Maria Manczak et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation
Hai-Yan Wu et al.
JOURNAL OF NEUROSCIENCE (2010)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Xinglong Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice
Virginie Rhein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy Lights and Shadows
Domenico Pratico
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice
Anne Eckert et al.
NEURODEGENERATIVE DISEASES (2008)
Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins
Xinglong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
P. Hemachandra Reddy et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Intracellular amyloid-β in Alzheimer's disease
Frank M. LaFerla et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Potent mitochondria-targeted peptides reduce myocardial infarction in rats
Janghyun Cho et al.
CORONARY ARTERY DISEASE (2007)
Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function
Dolca A. Thomas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction
Latha Devi et al.
JOURNAL OF NEUROSCIENCE (2006)
Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis
Susanne Petri et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Involvement of oxidative stress in Alzheimer disease
Akihiko Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons:: implications for free radical generation and oxidative damage in disease progression
M Manczak et al.
HUMAN MOLECULAR GENETICS (2006)
Targeting antioxidants to mitochondria: A new therapeutic direction
SS Sheu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease
PH Reddy
JOURNAL OF NEUROCHEMISTRY (2006)
Mitochondrial oxidative damage in aging and Alzheimer's disease: Implications for mitochondrially targeted antioxidant therapeutics
P. Hemachandra Reddy
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents
Hazel H. Szeto
AAPS JOURNAL (2006)
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
CG Almeida et al.
NEUROBIOLOGY OF DISEASE (2005)
Mitochondrial Aβ:: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease
C Caspersen et al.
FASEB JOURNAL (2005)
Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
PH Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42
PJ Crouch et al.
JOURNAL OF NEUROSCIENCE (2005)
Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain
RH Takahashi et al.
JOURNAL OF NEUROSCIENCE (2004)
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury
KS Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease
PH Reddy et al.
HUMAN MOLECULAR GENETICS (2004)
Synaptic changes in Alzheimer's disease -: Increased amyloid-β and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence
KH Gylys et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice
F Li et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide
DA Butterfield et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Synthesis and in vitro opioid activity profiles of DALDA analogues
PW Schiller et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
I Maurer et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
